News | Docs Dock

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Moderna completes enrollment for phase 2 trial of mRNA-1273

Anthony DiMoro
July 9, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Unum Therapeutics acquires kinase inhibitors developer Kiq

Anthony DiMoro
July 6, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News

BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS

Anthony DiMoro
July 3, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

China’s CF PharmTech raises $50m in Series F round for inhalation products

Anthony DiMoro
July 2, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

India-based Piramal Pharma secures $490m investment from Carlyle Group

Anthony DiMoro
June 30, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

EC approves Reblozyl for transfusion-dependent anemia in adults

Anthony DiMoro
June 28, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Masimo gets FDA clearance for Centroid patient monitoring sensor

Anthony DiMoro

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders

Anthony DiMoro
June 27, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics

Anthony DiMoro
June 25, 2020

<img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar lazyload" data-src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="avatar" src="https://secure.gravatar.com/avatar/d40a6dba6a738388749345c7a33fde82?s=51&d=mm&r=g" alt="image">

News, Pharma

Roche gets FDA nod for cobas EZH2 Mutation Test as companion diagnostic for follicular lymphoma patients

Anthony DiMoro
June 20, 2020

«
1
2
3
4
»